MetaADEDB 2.0 @ LMMD
CH5424802
(KDGFLJKFZUIJMX-UHFFFAOYSA-N)
Structure
SMILES
CCc1cc2C(=O)c3c4ccc(cc4[nH]c3C(c2cc1N1CCC(CC1)N1CCOCC1)(C)C)C#N
Type(s)
Approved; Investigational
ATC code(s)
L01XE36
Molecular Formula:
C30H34N4O2
Molecular Weight:
482.617
Log P:
4.7762
Hydrogen Bond Acceptor:
5
Hydrogen Bond Donor:
1
TPSA:
72.36
CAS Number(s):
1256580-46-7
Synonym(s)
1.
CH5424802
2.
RO5424802
3.
alectinib
External Link(s)
MeSHC582670
PubChem Compound49806720
BindingDB50362781
ChEBI90936
CHEMBLCHEMBL1738797
DrugBankDB11363
DrugCentral4937
IUPHAR/BPS Guide to PHARMACOLOGY7739
KEGGdr:D10450
dr:D10542
Therapeutic Target DatabaseD09TDZ
D0U3SY
ZINC66166864
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1FatigueFAERS: 68US FAERS
2ConstipationFAERS: 57US FAERS
3No adverse eventFAERS: 43US FAERS
4MyalgiaFAERS: 30US FAERS
5PneumoniaFAERS: 25US FAERS
6Drug ineffectiveFAERS: 22
Canada Vigilance: 1
Canada Vigilance
US FAERS
7Intentional product use issueFAERS: 21US FAERS
8Peripheral swellingFAERS: 21US FAERS
9ArthralgiaFAERS: 15US FAERS
10AstheniaFAERS: 15US FAERS
11BradycardiaFAERS: 15US FAERS
12PainFAERS: 14US FAERS
13Disease ProgressionFAERS: 13
Canada Vigilance: 1
Canada Vigilance
US FAERS
14Blood creatine phosphokinase increasedFAERS: 10US FAERS
15NauseaFAERS: 10US FAERS
16PneumonitisFAERS: 10US FAERS
17HeadacheFAERS: 9US FAERS
18Pericardial effusionFAERS: 9US FAERS
19Product storage errorFAERS: 9US FAERS
20AlopeciaFAERS: 8US FAERS
21Blood creatinine increasedFAERS: 8US FAERS
22Bone painFAERS: 7US FAERS
23DizzinessFAERS: 7US FAERS
24DysgeusiaFAERS: 7US FAERS
25PruritusFAERS: 7US FAERS
26Visual ImpairmentFAERS: 7US FAERS
27Back PainFAERS: 6US FAERS
28Drug dispensing errorFAERS: 6US FAERS
29FractureFAERS: 6US FAERS
30Intestinal ObstructionFAERS: 6US FAERS
31Joint swellingFAERS: 6US FAERS
32SwellingFAERS: 6US FAERS
33ErythemaFAERS: 5US FAERS
34Intercepted product storage errorFAERS: 5US FAERS
35Memory impairmentFAERS: 5US FAERS
36Transaminases increasedFAERS: 5US FAERS
37VomitingFAERS: 5US FAERS
38Blood glucose increasedFAERS: 4US FAERS
39Cerebrovascular accidentFAERS: 4US FAERS
40Chest PainFAERS: 4US FAERS
41Drug dose omissionFAERS: 4US FAERS
42Dry skinFAERS: 4US FAERS
43HypotensionFAERS: 4US FAERS
44InfluenzaFAERS: 4US FAERS
45Ocular icterusFAERS: 4US FAERS
46Pulmonary EmbolismFAERS: 4US FAERS
47Therapy cessationFAERS: 4US FAERS
48ThrombosisFAERS: 4US FAERS
49UrticariaFAERS: 4US FAERS
50Abdominal PainFAERS: 3US FAERS
51Abdominal discomfortFAERS: 3US FAERS
52AmnesiaFAERS: 3US FAERS
53ArthritisFAERS: 3US FAERS
54Blood lactate dehydrogenase increasedFAERS: 3US FAERS
55Cardiac TamponadeFAERS: 3US FAERS
56ChromaturiaFAERS: 3US FAERS
57Circumstance or information capable of leading to medication errorFAERS: 3US FAERS
58EpilepsyFAERS: 3US FAERS
59HepatitisFAERS: 3US FAERS
60HypoxiaFAERS: 3US FAERS
61Incorrect dose administeredFAERS: 3US FAERS
62Intercepted medication errorFAERS: 3US FAERS
63LethargyFAERS: 3US FAERS
64MalaiseFAERS: 3US FAERS
65Musculoskeletal PainFAERS: 3US FAERS
66PregnancyFAERS: 3US FAERS
67TachycardiaFAERS: 3US FAERS
68Therapy non-responderFAERS: 3US FAERS
69Wrong technique in product usage processFAERS: 3US FAERS
70jaundiceFAERS: 3US FAERS
71AnxietyFAERS: 2US FAERS
72AppendicitisFAERS: 2US FAERS
73Aspartate Aminotransferase IncreasedFAERS: 2US FAERS
74Atrial FibrillationFAERS: 2US FAERS
75Atrioventricular BlockFAERS: 2US FAERS
76Bilirubin conjugated increasedFAERS: 2US FAERS
77Blood alkaline phosphatase increasedFAERS: 2US FAERS
78Blood bilirubin unconjugated increasedFAERS: 2US FAERS
79ChillsFAERS: 2US FAERS
80DeafnessFAERS: 2US FAERS
81Depressed Level of ConsciousnessFAERS: 2US FAERS
82DisorientationFAERS: 2US FAERS
83DysgraphiaFAERS: 2US FAERS
84Emotional disorderFAERS: 2US FAERS
85Extra dose administeredFAERS: 2US FAERS
86HepatotoxicityFAERS: 2US FAERS
87Incorrect product storageFAERS: 2US FAERS
88Increased tendency to bruiseFAERS: 2US FAERS
89InfectionFAERS: 2US FAERS
90Intentional product misuseFAERS: 2US FAERS
91Metastatic NeoplasmFAERS: 2US FAERS
92Muscle FatigueFAERS: 2US FAERS
93Myocardial InfarctionFAERS: 2US FAERS
94MyopathyFAERS: 2US FAERS
95MyositisFAERS: 2US FAERS
96NasopharyngitisFAERS: 2US FAERS
97NecrosisFAERS: 2US FAERS
98PalpitationsFAERS: 2US FAERS
99Product dose omissionFAERS: 2US FAERS
100Product packaging quantity issueFAERS: 2US FAERS
101Productive CoughFAERS: 2US FAERS
102Respiratory FailureFAERS: 2US FAERS
103SepsisFAERS: 2US FAERS
104Throat irritationFAERS: 2US FAERS
105TinnitusFAERS: 2US FAERS
106Urinary tract infectionFAERS: 2US FAERS
107Weight decreasedFAERS: 2US FAERS
108White blood cell count decreasedFAERS: 2US FAERS
109AbasiaFAERS: 1US FAERS
110Abscess of eyelidFAERS: 1US FAERS
111Accidental overdoseFAERS: 1US FAERS
112Acute kidney injuryFAERS: 1US FAERS
113Alanine Aminotransferase IncreasedFAERS: 1US FAERS
114Altered state of consciousnessFAERS: 1US FAERS
115AngerFAERS: 1US FAERS
116Angina PectorisFAERS: 1US FAERS
117AphasiaFAERS: 1US FAERS
118AscitesFAERS: 1US FAERS
119AsthmaFAERS: 1US FAERS
120AtelectasisFAERS: 1US FAERS
121BlindnessFAERS: 1US FAERS
122Blood count abnormalFAERS: 1US FAERS
123Blood potassium decreasedFAERS: 1US FAERS
124Blood triglycerides increasedFAERS: 1US FAERS
125Bone lesionFAERS: 1US FAERS
126Brain natriuretic peptide increasedFAERS: 1US FAERS
127Burning sensationFAERS: 1US FAERS
128Carcinoembryonic antigen increasedFAERS: 1US FAERS
129CellulitisFAERS: 1US FAERS
130Cerebral disorderFAERS: 1US FAERS
131Chest discomfortFAERS: 1US FAERS
132ChokingFAERS: 1US FAERS
133CholelithiasisFAERS: 1US FAERS
134CoccidioidomycosisFAERS: 1US FAERS
135ColitisFAERS: 1US FAERS
136Contraindicated product administeredFAERS: 1US FAERS
137CraniotomyFAERS: 1US FAERS
138CystitisFAERS: 1US FAERS
139Cytomegalovirus enterocolitisFAERS: 1US FAERS
140CytopeniaFAERS: 1US FAERS
141Deep Vein ThrombosisFAERS: 1US FAERS
142DehydrationFAERS: 1US FAERS
143DementiaFAERS: 1US FAERS
144Device related infectionFAERS: 1US FAERS
145Disease recurrenceFAERS: 1US FAERS
146DiverticulitisFAERS: 1US FAERS
147Dose calculation errorFAERS: 1US FAERS
148Drug administration errorFAERS: 1US FAERS
149DyspepsiaFAERS: 1US FAERS
150DysphoniaFAERS: 1US FAERS
151DysuriaFAERS: 1US FAERS
152Emotional distressFAERS: 1US FAERS
153EnterocolitisFAERS: 1US FAERS
154EpistaxisFAERS: 1US FAERS
155Erythema MultiformeFAERS: 1US FAERS
156ExophthalmosFAERS: 1US FAERS
157Eye InfectionFAERS: 1US FAERS
158False positive investigation resultFAERS: 1US FAERS
159Feeling ColdFAERS: 1US FAERS
160Feeling abnormalFAERS: 1US FAERS
161Fibrin D dimer increasedFAERS: 1US FAERS
162FlatulenceFAERS: 1US FAERS
163FlushingFAERS: 1US FAERS
164Foreign body in respiratory tractFAERS: 1US FAERS
165FormicationFAERS: 1US FAERS
166Full blood count decreasedFAERS: 1US FAERS
167Gamma-Glutamyltransferase IncreasedFAERS: 1US FAERS
168Gastric DilatationFAERS: 1US FAERS
169GlaucomaFAERS: 1US FAERS
170GoutFAERS: 1US FAERS
171Haptoglobin DecreasedFAERS: 1US FAERS
172HemiparesisFAERS: 1US FAERS
173Hepatic necrosisFAERS: 1US FAERS
174Hip surgeryFAERS: 1US FAERS
175HydronephrosisFAERS: 1US FAERS
176HydrothoraxFAERS: 1US FAERS
177HypersensitivityFAERS: 1US FAERS
178HypersomniaFAERS: 1US FAERS
179HypertrichosisFAERS: 1US FAERS
180HypokinesiaFAERS: 1US FAERS
181Impaired gastric emptyingFAERS: 1US FAERS
182Inappropriate schedule of drug administrationFAERS: 1US FAERS
183Inappropriate schedule of product administrationFAERS: 1US FAERS
184Incorrect product formulation administeredFAERS: 1US FAERS
185Infrequent bowel movementsFAERS: 1US FAERS
186Intercepted drug dispensing errorFAERS: 1US FAERS
187Intestinal PerforationFAERS: 1US FAERS
188Iron deficiencyFAERS: 1US FAERS
189Large intestine perforationFAERS: 1US FAERS
190LeukocytosisFAERS: 1US FAERS
191Ligament painFAERS: 1US FAERS
192Lymphangiosis carcinomatosaFAERS: 1US FAERS
193MYELODYSPLASTIC SYNDROMEFAERS: 1US FAERS
194Malignant neoplasm of thymusFAERS: 1US FAERS
195Medication ErrorFAERS: 1US FAERS
196MeningitisFAERS: 1US FAERS
197Mental impairmentFAERS: 1US FAERS
198Metastases to pelvisFAERS: 1US FAERS
199MetastasisFAERS: 1US FAERS
200Muscle tightnessFAERS: 1US FAERS
201Musculoskeletal chest painFAERS: 1US FAERS
202Myocardial necrosis marker increasedFAERS: 1US FAERS
203Neck PainFAERS: 1US FAERS
204Nephritic syndromeFAERS: 1US FAERS
205Nephrotic SyndromeFAERS: 1US FAERS
206NeuritisFAERS: 1US FAERS
207NeutropeniaFAERS: 1US FAERS
208Night sweatsFAERS: 1US FAERS
209Occupational exposure to productFAERS: 1US FAERS
210Oropharyngeal painFAERS: 1US FAERS
211Ovarian enlargementFAERS: 1US FAERS
212Palindromic rheumatismFAERS: 1US FAERS
213PancreatitisFAERS: 1US FAERS
214PericarditisFAERS: 1US FAERS
215Peripheral arterial occlusive diseaseFAERS: 1US FAERS
216PeritonitisFAERS: 1US FAERS
217PertussisFAERS: 1US FAERS
218PetechiaeFAERS: 1US FAERS
219PneumoperitoneumFAERS: 1US FAERS
220PolymyositisFAERS: 1US FAERS
221PolyuriaFAERS: 1US FAERS
222PresyncopeFAERS: 1US FAERS
223Product container seal issueFAERS: 1US FAERS
224Product preparation errorFAERS: 1US FAERS
225Product use complaintFAERS: 1US FAERS
226Product use in unapproved indicationFAERS: 1US FAERS
227Protein total decreasedFAERS: 1US FAERS
228Pulmonary FibrosisFAERS: 1US FAERS
229Pulmonary toxicityFAERS: 1US FAERS
230Radiation PneumonitisFAERS: 1US FAERS
231Reduced facial expressionFAERS: 1US FAERS
232RhabdomyolysisFAERS: 1US FAERS
233RhinalgiaFAERS: 1US FAERS
234SciaticaFAERS: 1US FAERS
235Septic ShockFAERS: 1US FAERS
236SinusitisFAERS: 1US FAERS
237Skin reactionFAERS: 1US FAERS
238Slow speechFAERS: 1US FAERS
239SomnolenceFAERS: 1US FAERS
240StomatitisFAERS: 1US FAERS
241StressFAERS: 1US FAERS
242Sudden deathFAERS: 1US FAERS
243SunburnFAERS: 1US FAERS
244Thermal burnFAERS: 1US FAERS
245Toxicity to various agentsFAERS: 1US FAERS
246UlcerFAERS: 1US FAERS
247Unevaluable eventFAERS: 1US FAERS
248Uterine CancerFAERS: 1US FAERS
249Venous ThrombosisFAERS: 1US FAERS
250Ventricular arrhythmiaFAERS: 1US FAERS
251WheezingFAERS: 1US FAERS
252Wrong doseFAERS: 1US FAERS
253treatment failureFAERS: 1US FAERS
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120295

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.